HomeITRM • NASDAQ
add
Iterum Therapeutics PLC
Previous close
$1.31
Day range
$1.27 - $1.36
Year range
$0.81 - $3.02
Market cap
36.87M USD
Avg Volume
517.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.42M | -70.12% |
Net income | -6.58M | 46.76% |
Net profit margin | — | — |
Earnings per share | -0.12 | 85.19% |
EBITDA | -3.41M | 68.98% |
Effective tax rate | -0.38% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.12M | 0.81% |
Total assets | 44.60M | 69.83% |
Total liabilities | 48.68M | 49.03% |
Total equity | -4.08M | — |
Shares outstanding | 34.58M | — |
Price to book | -10.08 | — |
Return on assets | -30.32% | — |
Return on capital | -34.81% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -6.58M | 46.76% |
Cash from operations | -4.26M | 66.86% |
Cash from investing | 1.10M | -91.87% |
Cash from financing | 13.88M | 2,256.03% |
Net change in cash | 10.72M | 754.10% |
Free cash flow | -4.85M | 40.75% |
About
Founded
2015
Website
Employees
9
